These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34994965)

  • 81. Corporate Accountability Towards Species Extinction Protection: Insights from Ecologically Forward-Thinking Companies.
    Roberts L; Nandy M; Hassan A; Lodh S; Elamer AA
    J Bus Ethics; 2022; 178(3):571-595. PubMed ID: 33867604
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cultivating Excellence: Future-Proofing Medical Affairs with Tailored Talent Programs.
    Reis F; Rajaeean N; Divarci RR; Sollacher V; Dworatzek E; Fliegner D; Krüger H; Lenz C; Craesmeyer C
    Pharmaceut Med; 2024 Sep; 38(5):355-363. PubMed ID: 39090508
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders.
    Cui W; Phillips KA; Anderson RA; Francis PA; Loi S; Loibl S; Partridge AH; Keogh LA
    Am J Cancer Res; 2022; 12(12):5599-5612. PubMed ID: 36628283
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Medical Affairs and Innovative Medicinal Product Strategy Development.
    Krendyukov A; Nasy D
    Pharmaceut Med; 2022 Apr; 36(2):71-82. PubMed ID: 35279795
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The Value and Deliverables of Medical Affairs: Affiliate Perspectives and Future Expectations.
    Farrington AD; Frøstrup AG; Dahl P
    Pharmaceut Med; 2023 Nov; 37(6):417-424. PubMed ID: 37789114
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A practical approach to communicating benefit-risk decisions of medicines to stakeholders.
    Leong J; Walker S; Salek S
    Front Pharmacol; 2015; 6():99. PubMed ID: 26124720
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Patent "Evergreening" of Medicine-Device Combination Products: A Global Perspective.
    Beall RF; Glazer T; Ahmad H; Buell M; Hahn S; Houston AR; Kesselheim AS; Nickerson JW; Kaplan W
    Healthc Policy; 2022 Oct; 18(2):14-26. PubMed ID: 36495532
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The Emotional Dimension of Value: A Proposal for Its Quantitative Measurement.
    Ruiz-Roqueñi M
    Front Psychol; 2021; 12():807412. PubMed ID: 35185704
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The medical science liaison role in Spain: A nationwide survey.
    Sastre V; Matesanz-Marín A; García C; González Del Castillo A
    Perspect Clin Res; 2022; 13(1):48-53. PubMed ID: 35198429
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities.
    Fröling E; Rajaeean N; Hinrichsmeyer KS; Domrös-Zoungrana D; Urban JN; Lenz C
    Pharmaceut Med; 2024 Sep; 38(5):331-342. PubMed ID: 39259426
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evolving role of pharmaceutical physicians in medical evidence and education.
    Setia S; Ryan NJ; Nair PS; Ching E; Subramaniam K
    Adv Med Educ Pract; 2018; 9():777-790. PubMed ID: 30464675
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Development and Validation of the Medical Affairs Pharmaceutical Physician Value (MAPPval) Instrument.
    Jandhyala R
    Pharmaceut Med; 2022 Feb; 36(1):47-57. PubMed ID: 34994965
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Observing expert opinion of medical affairs pharmaceutical physicians on the value of their clinical experience to the pharmaceutical industry using the Jandhyala method.
    Jandhyala R; Rout R
    Curr Med Res Opin; 2023 Dec; 39(12):1541-1550. PubMed ID: 36632732
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Professional qualifications of medical affairs pharmaceutical physicians and other internal stakeholders in the pharmaceutical industry.
    Jandhyala R
    F1000Res; 2022; 11():813. PubMed ID: 36415210
    [No Abstract]   [Full Text] [Related]  

  • 95. Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.
    Jandhyala R
    Front Pharmacol; 2022; 13():842431. PubMed ID: 35273511
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.